Arantxa Isla

2.1k total citations
59 papers, 1.6k citations indexed

About

Arantxa Isla is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, Arantxa Isla has authored 59 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pharmacology, 18 papers in Molecular Medicine and 16 papers in Epidemiology. Recurrent topics in Arantxa Isla's work include Antibiotics Pharmacokinetics and Efficacy (40 papers), Antibiotic Resistance in Bacteria (18 papers) and Antibiotic Use and Resistance (12 papers). Arantxa Isla is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (40 papers), Antibiotic Resistance in Bacteria (18 papers) and Antibiotic Use and Resistance (12 papers). Arantxa Isla collaborates with scholars based in Spain, United States and Chile. Arantxa Isla's co-authors include Alicia Rodríguez‐Gascón, Maria Ángelés Solinís, Eduardo Asín‐Prieto, Javier Maynar, Andrés Canut, José Luís Pedraz, Helena Barrasa, José Ángel Sánchez‐Izquierdo, Esther Corral and Iñaki F. Trocóniz and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Antimicrobial Chemotherapy and Clinical Pharmacokinetics.

In The Last Decade

Arantxa Isla

56 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arantxa Isla Spain	24	951	451	393	219	200	59	1.6k
Lavern M. Vercaigne Canada	20	700 0.7×	625 1.4×	481 1.2×	297 1.4×	118 0.6×	40	1.7k
Maya Hites Belgium	24	777 0.8×	629 1.4×	335 0.9×	417 1.9×	302 1.5×	77	1.5k
Olaf Burkhardt Germany	27	728 0.8×	1.0k 2.3×	390 1.0×	422 1.9×	266 1.3×	56	2.1k
I. Nilsson-Ehle Sweden	24	865 0.9×	357 0.8×	318 0.8×	216 1.0×	96 0.5×	58	1.8k
Nathaniel J. Rhodes United States	23	936 1.0×	577 1.3×	506 1.3×	518 2.4×	231 1.2×	96	1.6k
Fekade B. Sime Australia	24	1.2k 1.3×	645 1.4×	731 1.9×	205 0.9×	417 2.1×	87	1.8k
Olivier Petitjean France	22	667 0.7×	450 1.0×	330 0.8×	246 1.1×	84 0.4×	89	1.6k
Paul M. Beringer United States	22	500 0.5×	362 0.8×	286 0.7×	333 1.5×	83 0.4×	64	1.4k
Wolfgang A. Krueger Germany	21	345 0.4×	552 1.2×	315 0.8×	317 1.4×	176 0.9×	44	1.5k
Sandrine Marchand France	28	1.3k 1.4×	758 1.7×	1.1k 2.8×	238 1.1×	176 0.9×	116	2.5k

Countries citing papers authored by Arantxa Isla

Since Specialization

Citations

This map shows the geographic impact of Arantxa Isla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arantxa Isla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arantxa Isla more than expected).

Fields of papers citing papers by Arantxa Isla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arantxa Isla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arantxa Isla. The network helps show where Arantxa Isla may publish in the future.

Co-authorship network of co-authors of Arantxa Isla

This figure shows the co-authorship network connecting the top 25 collaborators of Arantxa Isla. A scholar is included among the top collaborators of Arantxa Isla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arantxa Isla. Arantxa Isla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barrasa, Helena, Miguel Ángel Morán Rodríguez, Arantxa Isla, et al.. (2024). Optimizing Antibiotic Therapy for Stenotrophomonas maltophilia Infections in Critically Ill Patients: A Pharmacokinetic/Pharmacodynamic Approach. Antibiotics. 13(6). 553–553. 7 indexed citations

Benrimoj, Shalom I., Estíbaliz Goyenechea, Arantxa Isla, et al.. (2024). Outcomes of Community Pharmacy Interventions on Patients with Medicines Under Additional Monitoring. PubMed. Volume 13. 115–125. 1 indexed citations

Rodríguez‐Gascón, Alicia, et al.. (2023). Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections?. Pharmaceutics. 15(4). 1185–1185. 1 indexed citations

Barrasa, Helena, Javier Maynar, Andrés Canut-Blasco, et al.. (2023). Ceftaroline and Avibactam Removal by Continuous Renal Replacement Therapies: An in vitro Study. Blood Purification. 52(5). 464–473. 2 indexed citations

Barrasa, Helena, Alicia Rodríguez‐Gascón, Eduardo Asín‐Prieto, et al.. (2022). Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study. Journal of Intensive Care. 10(1). 21–21. 9 indexed citations

Isla, Arantxa, et al.. (2020). Farmazia-zerbitzu profesional asistentzialak Euskal Autonomia Erkidegoko (EAE) farmazietan. EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria. 131–152. 1 indexed citations

Lertxundi, Unax, et al.. (2020). Pharmacotherapeutic management of Parkinson’s disease inpatients: how about asking hospital pharmacists?. European Journal of Hospital Pharmacy. 28(e1). e140–e145. 3 indexed citations

Rodríguez-Castejón, Julen, Itziar Gómez-Aguado, Mónica Vicente-Pascual, et al.. (2019). Gene-terapia: Ikuspegi terapeutiko berria begietako gaitzen tratamenduan. EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria. 31–48. 1 indexed citations

Rodríguez‐Gascón, Alicia, et al.. (2018). Augmented Renal Clearance in Critically Ill Patients: A Systematic Review. Clinical Pharmacokinetics. 57(9). 1107–1121. 151 indexed citations

10.

Asín‐Prieto, Eduardo, Alicia Rodríguez‐Gascón, Helena Barrasa, et al.. (2018). Population pharmacokinetics of daptomycin in critically ill patients. International Journal of Antimicrobial Agents. 52(2). 158–165. 34 indexed citations

11.

Lertxundi, Unax, Saioa Domingo‐Echaburu, Maria Ángelés Solinís, et al.. (2017). Hiccups in Parkinson’s disease: an analysis of cases reported in the European pharmacovigilance database and a review of the literature. European Journal of Clinical Pharmacology. 73(9). 1159–1164. 9 indexed citations

12.

Asín‐Prieto, Eduardo, et al.. (2015). Population pharmacokinetic models for cefuroxime and metronidazole used in combination as prophylactic agents in colorectal surgery: Model-based evaluation of standard dosing regimens. International Journal of Antimicrobial Agents. 45(5). 504–511. 17 indexed citations

13.

Lertxundi, Unax, Arantxa Isla, Maria Ángelés Solinís, et al.. (2015). Anticholinergic burden in Parkinson’s disease inpatients. European Journal of Clinical Pharmacology. 71(10). 1271–1277. 23 indexed citations

14.

Beloqui, Ana, Maria Ángelés Solinís, Araceli Delgado, et al.. (2013). Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution. Journal of Microencapsulation. 31(1). 1–8. 43 indexed citations

15.

Asín‐Prieto, Eduardo, Alicia Rodríguez‐Gascón, Iñaki F. Trocóniz, et al.. (2013). Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis. Journal of Antimicrobial Chemotherapy. 69(1). 180–189. 58 indexed citations

16.

Isla, Arantxa, et al.. (2011). Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain. Enfermedades Infecciosas y Microbiología Clínica. 29(3). 167–173. 19 indexed citations

17.

Maynar, Javier, Alicia Rodríguez‐Gascón, Arantxa Isla, et al.. (2005). Influence of Renal Function on the Pharmacokinetics of Piperacillin/Tazobactam in Intensive Care Unit Patients During Continuous Venovenous Hemofiltration. The Journal of Clinical Pharmacology. 45(2). 168–176. 59 indexed citations

18.

Isla, Arantxa, et al.. (2005). Determination of ceftazidime and cefepime in plasma and dialysate-ultrafiltrate from patients undergoing continuous veno-venous hemodiafiltration by HPLC. Journal of Pharmaceutical and Biomedical Analysis. 39(5). 996–1005. 34 indexed citations

19.

Isla, Arantxa, Javier Maynar, José Ángel Sánchez‐Izquierdo, et al.. (2005). Meropenem and Continuous Renal Replacement Therapy: In Vitro Permeability of 2 Continuous Renal Replacement Therapy Membranes and Influence of Patient Renal Function on the Pharmacokinetics in Critically Ill Patients. The Journal of Clinical Pharmacology. 45(11). 1294–1304. 47 indexed citations

20.

Canut, Andrés, et al.. (2005). Evaluation of Antimicrobial Treatments in Children with Acute Otitis Media in Spain: A Pharmacokinetic-Pharmacodynamic (PK/PD) Approach. Journal of Chemotherapy. 17(6). 628–635. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact